MENU

UTMD Stock Utah Medical Products (UTMD, $57.15) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 18, 2025

A.I.dvisor
at Tickeron.com
Loading...
UTMD - Utah Medical Products
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $57.15
Daily change: +$1.67 (+3.01%)
Daily volume: 17.2K
Capitalization: $183.2M
Industry: Pharmaceuticals: Other
This is a Bullish indicator signaling UTMD's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 52 similar cases where UTMD's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

Aroon Indicator for UTMD shows an upward move is likely

UTMD's Aroon Indicator triggered a bullish signal on July 31, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 106 similar instances where the Aroon Indicator showed a similar pattern. In of the 106 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2025. You may want to consider a long position or call options on UTMD as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for UTMD just turned positive on August 18, 2025. Looking at past instances where UTMD's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

UTMD moved above its 50-day moving average on August 18, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for UTMD crossed bullishly above the 50-day moving average on August 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UTMD advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UTMD broke above its upper Bollinger Band on August 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.693) is normal, around the industry mean (10.755). P/E Ratio (16.549) is within average values for comparable stocks, (57.297). UTMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.848). Dividend Yield (0.020) settles around the average of (0.016) among similar stocks. P/S Ratio (5.359) is also within normal values, averaging (37.913).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UTMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UTMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a manufacturer of specialty medical devices for the healthcare industry

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
7043 South 300 West
Phone
+1 801 566-1200
Employees
216
Web
http://www.utahmed.com